✦ LIBER ✦

Pharmacokinetics of the diastereomers of arteether, a potent antimalarial drug, in rats

✍ Scribed by S. Sabarinath; K. P. Madhusudanan; R. C. Gupta

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 166 KB
Volume: 26
Category: Article
ISSN: 0142-2782
DOI: 10.1002/bdd.452

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Pharmacokinetics, M

ChemInform Abstract: Pharmacokinetics, Metabolism and Excretion of Megazol, a New Potent Trypanocidal Drug in Animals.

✍ Bertin Enanga; Hamid Boudra; Gerard Chauviere; Christian Labat; Bernard Bouteill 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

Stereoselective pharmacokinetics of [14C

Stereoselective pharmacokinetics of [14C]-labeled KE-298, a new anti-rheumatic drug, in rats

✍ Hideo Yoshida; Yoshiro Kohno; Hiromi Endo; Masatoshi Hasegawa; Toshio Suwa 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

The stereoselective pharmacokinetics of two enantiomers of [14C]-labeled -(4-methylphenyl)-4-oxobutanonic acid] were investigated in rats. The blood levels of radioactivity after the oral administration of (+)-(S)-[14C]KE-298 were higher than that for (-)-(R)-[14C]KE-298; the AUC of the former was a

Alteration of the intravenous pharmacoki

Alteration of the intravenous pharmacokinetics of a synthetic ozonide antimalarial in the presence of a modified cyclodextrin

✍ Susan A. Charman; Christine S. Perry; Francis C.K. Chiu; Kylie A. McIntosh; Rich 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

The pharmacokinetic profile and renal clearance of a novel synthetic ozonide antimalarial (1) was found to be significantly altered when intravenously administered to rats as a cyclodextrin-based formulation (0.1 M Captisol, a sulfobutylether beta-cyclodextrin derivative (SBE(7)-beta-CD)) compared t

Pharmacokinetics of SB-247083, a potent

Pharmacokinetics of SB-247083, a potent and selective endothelinA receptor antagonist, in the rat, dog, and monkey

✍ Keith W. Ward; Leonard M. Azzarano; Jayme A. Morgan; Michael J. Gould; Cherng-Yi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Alterations in the cardiopulmonary effec

Alterations in the cardiopulmonary effects and pharmacokinetics of a bisphosphonate drug by a cytochrome P-450 inhibitor in conscious rats

✍ B. K. J. Leong; C. P. Sabaitis; D. A. Rop; P. Jeffrey; T. J. Parker; N. K. Burto 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Key words: bisphosphonate; P-450 inhibitor, pharmacokinetics; cardiopulmonary; conscious rat U-91502, a bisphosphonate for arthritic inflammation treatment, was evaluated for its parental toxicity. The objective was to differentiate between the parent drug and a reactive metabolite(s) as the proxima

Stereoselective pharmacokinetics of desb

Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drug

✍ Dion R. Brocks 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract The main objective of this study was to determine the pharmacokinetics of the enantiomers of desbutylhalofantrine (DHF), a metabolite of halofantrine (HF), in the rat. Rats received either intravenous (2 mg/kg) or oral (7 mg/kg) (±)‐DHF HCl, or (±)‐HF HCl intravenously (3 mg/kg). Enanti